approved

Приложение 4 от 02.11.2016

Unique identificator:  3e292905-ef8b-4985-bea5-aeb01d62af04

здравеопазване лекарства реимбурсиране

Current version: 1

Displayed version: 1

Format: CSV

  • Created at: 2016-11-09 09:28:59
  • Created by: georgi_sivchev
  • Updated at: 2018-10-16 08:08:28
  • Updated by: migrate_data
records per page
Order by:

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Dorzolamide II-1823/31.03.2008 Trusopt, -, 2% - 5ml, mg, Pack: 1 Мерк Шарп и Доум България ЕООД, България Laboratoires Merck Sharp & Dohme – Chibret (Mirabel Plant), Route de Marsat, F-63963, Clermont –Ferranf cedex 9, France 10.68 2.14 12.82 6% 0.64 11.32 2.26 13.58 18% 1.92 13.24 2.65 15.89 КЦ-3144/04.11.2011 12.02.2012 12.02.2012 Неактивен 2548
Dorzolamide II-1823/31.03.2008 Trusopt, -, 2% - 5ml, mg, Pack: 1 Мерк Шарп и Доум България ЕООД, България Merck Sharp & Dohme B.V.- The Netherlands; Laboratoire Merck Sharp & Dohme - Chilbert, Mirabel Plant-France 15.26 3.05 18.31 8% 1.22 16.48 3.3 19.78 20% 3.05 19.53 3.91 23.44 цената е променена КЦ-708/09.03.2009 24.03.2009 24.03.2009 Неактивен 2548
Emtricitabine, Tenofovir disoproxil EU/1/04/305/001 Truvada, Film coated tablet, 200 mg/245 mg, UD, Pack: 30 Gilead Sciences International Ltd., Обединено Кралство Gilead Sciences Limited,, Ирландия 815.7 163.14 978.84 4% 10 825.7 165.14 990.84 16% 25 850.7 170.14 1020.84 НСР-7001/24.08.2015. 08.09.2015 08.09.2015 Активен 3360
Emtricitabine, Tenofovir disoproxil EU/1/04/305/001 Truvada, Film coated tablet, 200 mg/245 mg, UD, Pack: 30 Gilead Sciences International Ltd., Обединено Кралство Gilead Sciences Limited,, Ирландия 823.89 164.78 988.67 4% 10 833.89 166.78 1000.67 16% 25 858.89 171.78 1030.67 НСР-5064/21.11.2014 08.12.2014 08.12.2014 Неактивен 3360
Solifenacin 20120213 Truzor, Film coated tablet, 5, mg, Pack: 30 Sandoz d.d., Словения Sanitas AB, Литва; Lek Pharmaceuticals d.d., Словения 27.11 5.42 32.53 6% 1.63 28.74 5.75 34.49 18% 4.88 33.62 6.72 40.34 НСР-5165/27.11.2014 11.12.2014 11.12.2014 Активен 3405
Solifenacin 20120213 Truzor, Film coated tablet, 5, mg, Pack: 30 Sandoz d.d., Словения Sanitas AB, Литва; Lek Pharmaceuticals d.d., Словения 31.29 6.26 37.55 4% 1.25 32.54 6.51 39.05 16% 5.01 37.55 7.51 45.06 НСР-1297/03.10.2013 18.10.2013 18.10.2013 Неактивен 3405
Rifampicin 9900243 TUBOCIN, Capsule, hard, 300, mg, Pack: 100 Актавис EАД, България Балканфарма Разград, България 26.66 5.33 31.99 6% 1.6 28.26 5.65 33.91 18% 4.8 33.06 6.61 39.67 HCР-410/03.07.2013. 18.07.2013 18.07.2013 Активен 1956
Rifampicin II-10182/28.12.2004 TUBOCIN, Capsule, hard, 300, mg, Pack: 100 Актавис EАД, България Балканфарма Разград, България 24 4.8 28.8 6% 1.44 25.44 5.09 30.53 18% 4.32 29.76 5.95 35.71 КЦ-507/06.02.2009 19.02.2009 19.02.2009 Неактивен 1956
Atorvastatin ІІ-14747/08.11.2006 г. TULIP, Film coated tablet, 10, mg, Pack: 30 Lek Pharmaceuticals d.d., Словения Lek Pharmaceutical d.d., Slovenia 2.23 0.45 2.68 7% 0.16 2.39 0.48 2.87 20% 0.45 2.84 0.57 3.41 Отхвърлена като неоснователна жалбата от Комисия по прозрачност КП-296/02.06.2015 НСР-3962/30.06.2014 16.06.2015 16.06.2015 Активен 3447
Atorvastatin ІІ-14748/08.11.2006 г. TULIP, Film coated tablet, 20, mg, Pack: 30 Lek Pharmaceuticals d.d., Словения Lek Pharmaceutical d.d., Slovenia 4.32 0.86 5.18 7% 0.3 4.62 0.92 5.54 20% 0.86 5.48 1.1 6.58 НСР-5320/ 18.12.2014. 01.01.2015 01.01.2015 Активен 3448
Atorvastatin ІІ-14747/08.11.2006 г. TULIP, Film coated tablet, 10, mg, Pack: 30 Lek Pharmaceuticals d.d., Словения Lek Pharmaceuti-cal d.d., Slovenia 2.58 0.52 3.1 7% 0.18 2.76 0.55 3.31 20% 0.52 3.28 0.66 3.94 НСР-5319/ 18.12.2014. 01.01.2015 01.01.2015 Неактивен 3447
Atorvastatin ІІ-14747/08.11.2006 г. TULIP, Film coated tablet, 10, mg, Pack: 30 Lek Pharmaceuticals d.d., Словения Lek Pharmaceutical d.d., Slovenia 3.36 0.67 4.03 7% 0.24 3.6 0.72 4.32 20% 0.67 4.27 0.85 5.12 НСР-1526/25.10.2013 12.11.2013 12.11.2013 Неактивен 3447
Atorvastatin ІІ-14748/08.11.2006 г. TULIP, Film coated tablet, 20, mg, Pack: 30 Lek Pharmaceuticals d.d., Словения Lek Pharmaceutical d.d., Slovenia 6.49 1.3 7.79 7% 0.45 6.94 1.39 8.33 20% 1.3 8.24 1.65 9.89 НСР-1527/25.10.2013 12.11.2013 12.11.2013 Неактивен 3448
Atorvastatin ІІ-14748/08.11.2006 г. TULIP, Film coated tablet, 20, mg, Pack: 30 Lek Pharmaceuticals d.d., Словения Lek Pharmaceutical d.d., Slovenia 7.2 1.44 8.64 7% 0.5 7.7 1.54 9.24 20% 1.44 9.14 1.83 10.97 КЦРР-785/15.06.2012 03.07.2012 03.07.2012 Неактивен 3448
Atorvastatin ІІ-14747/08.11.2006 г. TULIP, Film coated tablet, 10, mg, Pack: 30 Lek Pharmaceuticals d.d., Словения Lek Pharmaceutical d.d., Slovenia 4.13 0.83 4.96 7% 0.29 4.42 0.88 5.3 20% 0.83 5.25 1.05 6.3 КЦРР-785/15.06.2012 03.07.2012 03.07.2012 Неактивен 3447
Atorvastatin ІІ-14748/ 08.11.2006 г. TULIP, Film coated tablet, 20, mg, Pack: 30 Lek Pharmaceuticals d.d., Словения Lek Pharmaceuticals d.d., Slovenia 9.13 1.83 10.96 9% 0.82 9.95 1.99 11.94 22% 2.01 11.96 2.39 14.35 КЦРР-653/19.05.2012 04.06.2012 04.06.2012 Неактивен 3448
Atorvastatin ІІ-14747/08.11.2006 г. TULIP, Film coated tablet, 10, mg, Pack: 30 Lek Pharmaceuticals d.d., Словения Lek Pharmaceuticals d.d., Slovenia 5.71 1.14 6.85 9% 0.51 6.22 1.24 7.46 22% 1.26 7.48 1.5 8.98 КЦ-527/13.02.2009 02.03.2009 02.03.2009 Неактивен 3447
Atorvastatin ІІ-14748/08.11.2006 г. TULIP, Film coated tablet, 20, mg, Pack: 30 Lek Pharmaceuticals d.d., Словения Lek Pharmaceuticals d.d., Slovenia 11.44 2.29 13.73 8% 0.92 12.36 2.47 14.83 20% 2.29 14.65 2.93 17.58 КЦ-527/13.02.2009 02.03.2009 02.03.2009 Неактивен 3448
Hepatitis A (inactivated), hepatitis B (rDNA) (HAB) vaccine (adsorbed) EU/1/96/020/007 TWINRIX ADULT, Suspension for injection, 1ml, ml (1 dose = 1 ml), Pack: 1 pre-filled syringe + 1 separate needle GlaxoSmithKline Biologicals S.A., Белгия GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium 38.98 7.8 46.78 4% 1.56 40.54 8.11 48.65 16% 6.24 46.78 9.36 56.14 НСР-7782/28.12.2015 13.01.2016 13.01.2016 Активен 129
Hepatitis A (inactivated), hepatitis B (rDNA) (HAB) vaccine (adsorbed) EU/1/96/020/007 TWINRIX ADULT, Suspension for injection, 1ml, -, Pack: 1 pre-filled syringe + 1 separate needle GlaxoSmithKline Biologicals S.A., Белгия GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium 38.98 7.8 46.78 4% 1.56 40.54 8.11 48.65 16% 6.24 46.78 9.36 56.14 НСР-7782/28.12.2015 13.01.2016 13.01.2016 Неактивен 129
Hepatitis A (inactivated), hepatitis B (rDNA) (HAB) vaccine (adsorbed) EU/1/96/020/007 TWINRIX ADULT, Suspension for injection, 1ml, -, Pack: 1 pre-filled syringe + 1 separate needle GlaxoSmithKline Biologicals S.A., Белгия GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium 38.98 7.8 46.78 4% 1.56 40.54 8.11 48.65 16% 6.24 46.78 9.36 56.14 НСР-7782/28.12.2015 13.01.2016 13.01.2016 Неактивен 129
Hepatitis A (inactivated), hepatitis B (rDNA) (HAB) vaccine (adsorbed) ЕU/1/96/020/001-009 TWINRIX ADULT, Suspension for injection, 20 mcg/1 ml, 1 dose=1 ml, Pack: 1 GlaxoSmithKline Biologicals S.A., Белгия GlaxoSmithKline Biologicals S.A., Belgium 40.33 8.07 48.4 4% 1.61 41.94 8.39 50.33 16% 6.45 48.39 9.68 58.07 цената се заличава КЦРР-1641/15.11.2012 КЦРР-743/07.06.2012 26.06.2012 26.06.2012 Заличен 1244
Hepatitis A (inactivated), hepatitis B (rDNA) (HAB) vaccine (adsorbed) ЕU/1/96/020/001-009 TWINRIX ADULT, Suspension for injection, 20 mcg/1 ml, 1 dose=1 ml, Pack: 1 GlaxoSmithKline Biologicals S.A., Белгия GlaxoSmithKline Biologicals S.A., Belgium 42.36 8.47 50.83 6% 2.54 44.9 8.98 53.88 18% 7.62 52.52 10.5 63.02 КЦ-1483/31.03.2010 21.04.2010 21.04.2010 Неактивен 1244
Hepatitis A (inactivated), hepatitis B (rDNA) (HAB) vaccine (adsorbed) EU/1/96/020/007 Twinrix Adult suspension injection vial 20 mcg 1 ml, Hepatitis A virus (inactivated) 720 ELSA Units, Hepatitis B surface antigen 20 mcg x 1 dose, Suspension for injection, Hepatitis A virus (inactivated) 720 ELISA Units / Hepatitis B surface antigen 20 μg, 1 dose=1 ml, Pack: 1 GlaxoSmithKline Biologicals S.A., Белгия GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium 42.36 8.47 50.83 4% 1.69 44.05 8.81 52.86 16% 6.78 50.83 10.17 61 КЦ-262/27.10.2008 18.11.2008 18.11.2008 Неактивен 129
Telmisartan, Amlodipine EU/1/10/648/016 TWYNSTA, Tablet, 80 mg/ 5, mg, Pack: 28 Boehringer Ingelheim International GmbH, Германия Boehringer Ingelheim Pharma GmbH & Co. KG, Germany 29.81 5.96 35.77 6% 1.79 31.6 6.32 37.92 18% 5.37 36.97 7.39 44.36 НСР-7909/28.01.2016.; НСР-10439/29.09.2016 02.11.2016 02.11.2016 Активен 3098
Showing 9001 to 9026 of 9938 entries
Download link in CSV format: Copy
Download link in JSON format: Copy
Download link in XML format: Copy
 

Моля изчакайте